Baotou Dongbao Bio-tech announced that the company intends to repurchase the issued ordinary shares of RMB (A shares), with the total amount of repurchase funds not less than 50 million yuan (inclusive) and not exceeding 0.1 billion yuan (inclusive). The repurchase price will not exceed 8.00 yuan/share (inclusive), and the purpose of the repurchased shares is to implement the employee stock ownership plan or Stock-based Incentive. If the repurchased shares are not utilized within three years after the announcement of the results of this share repurchase and share changes, the unused repurchased shares will go through the relevant procedures for cancellation. The repurchase period is within 12 months from the date when the Board of Directors of the company approves the plan for share repurchase. The source of repurchase funds is the company's own funds and/or self-raised funds. This repurchase will not have a significant impact on the company's Operation, finances, and future development, nor will it affect the company's listing status.